BROMLEY CAPITAL LIMITED

Company number SC486285 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: BROMLEY CAPITAL LIMITED

1. Financial Health Score: B+

Explanation: The patient exhibits robust constitutional health with impressive asset growth and strong equity foundations. However, there are concerning symptoms of cash depletion and an elevated debtors reading that require monitoring. The underlying business model is sound, but short-term liquidity shows signs of strain that could become problematic if the property market softens or debtor collection stalls.


2. Key Vital Signs

Vital Sign Reading Assessment
Total Assets £8,031,548 (2025) Excellent – 12% growth from £7.17M (2024)
Shareholders' Funds £6,758,079 Healthy – 10% growth year-on-year
Cash at Bank £149,253 ⚠️ Concerning – 85% drop from £1,020,241
Current Liabilities £1,273,469 Moderate – 23% increase
Debtors £2,823,784 ⚠️ Elevated – 161% increase from £1,079,887
Investment Property £4,373,521 Strong – active portfolio management
Debt-to-Equity Ratio 18.8% Healthy – low leverage
Current Ratio 2.87:1 Healthy – good short-term coverage
Quick Ratio 2.33:1 Adequate – excluding stock
Retained Earnings Growth £617,695 profit Positive – profitable operations

Long-Term Growth Trajectory

The company has demonstrated exceptional growth over its lifetime:

Year Total Assets Shareholders' Funds Growth in Equity
2016 £666,056 £320,447 -
2018 £1,283,129 £901,360 181%
2020 £2,414,526 £1,462,678 62%
2022 £4,882,379 £3,751,569 156%
2024 £7,171,708 £6,140,384 64%
2025 £8,031,548 £6,758,079 10%

This represents a compound equity growth of approximately 46% annually over 9 years – an outstanding long-term record.


3. Diagnosis

What the Financial Data Reveals About Business Health

🟢 Healthy Symptoms:

Strong Asset Foundation: The company has built a substantial £8M asset base from virtually nothing over a decade. The investment property portfolio at £4.37M forms a solid core. Like a patient with excellent bone density, the structural foundation is robust.

Consistent Profitability: Retained earnings have grown every single year without exception, indicating the business model generates reliable profits. The £617,695 retained profit in 2025 demonstrates continued earning power.

Low Leverage: With debt-to-equity at just 18.8%, the company is not over-leveraged. This provides significant financial resilience – like having low blood pressure, it means the business can withstand economic shocks.

Active Portfolio Management: The 2025 accounts show significant property activity: - Additions: £2,878,706 - Disposals: £2,180,897 - This demonstrates an active trading strategy, not a passive portfolio

🟡 Symptoms Requiring Monitoring:

Cash Haemorrhage: The most alarming vital sign is the 85% drop in cash from £1,020,241 to £149,253. This is like a patient whose circulating blood volume has dropped dangerously low. While not immediately fatal given the strong asset base, it leaves the business vulnerable to unexpected costs or delayed income.

Elevated Debtors: Debtors have surged from £1,079,887 to £2,823,784 – a 161% increase. In medical terms, this resembles fluid retention – money that should be flowing through the system is instead pooling. This could represent: - Property sales awaiting completion (common in real estate) - Slower payment from counterparties - Related party balances

Stock Reduction: Stocks fell from £1,393,364 to £683,788, suggesting properties were sold or reclassified as investment property. This isn't necessarily concerning, but combined with high debtors, it suggests properties may have been sold on terms that haven't yet converted to cash.

🔴 Potential Risk Factors:

Concentration Risk: The company is entirely dependent on the UK real estate market. Any downturn in property values could directly impact the investment property valuation and stock values.

Single Director Dependency: With only one director (Mr Lal, who also holds >75% control), there's significant key-person risk. If Mr Lal becomes unavailable, business continuity could be compromised.

Limited Cash Buffer: With only £149,253 in cash against £1.27M in current liabilities, the cash ratio is just 0.12:1. While the overall current ratio is healthy (2.87:1), the business relies heavily on collecting debtors to meet obligations.


4. Recommendations

Specific Actions to Improve Financial Wellness

Immediate (0-3 months):

1. Cash Flow Resuscitation - Priority: Critical - Investigate the £2.8M debtors balance urgently. Identify which are property sales awaiting completion versus overdue balances. - Set a target to reduce debtors by 50% within 6 months through active collection. - Consider whether any debtors are related party balances requiring disclosure.

2. Cash Buffer Establishment - Priority: High - Target a minimum cash reserve of £300,000-£500,000 (3-6 months of operating costs). - Negotiate or establish a revolving credit facility as emergency backup.

Short-Term (3-6 months):

3. Debtors Aging Analysis - Priority: High - Request detailed aging report from the accountant. - Identify any provisions needed for doubtful debts. - Implement systematic follow-up procedures for collections.

4. Working Capital Planning - Priority: Medium - Map out property sale completion timelines to forecast when debtors will convert to cash. - Consider whether the timing of property acquisitions can be staggered to preserve cash.

Medium-Term (6-12 months):

5. Property Portfolio Stress Testing - Priority: Medium - Model the impact of a 10-20% decline in property values on the balance sheet. - Review whether any investment properties should be sold to build cash reserves. - Consider the implications of rising interest rates on property values and financing costs.

6. Business Continuity Planning - Priority: Medium - Given single-director dependency, document key business processes. - Consider appointing a second director or establishing a power of attorney. - Review succession planning and key-person insurance needs.

Ongoing:

7. Financial Health Monitoring - Track the following KPIs quarterly: - Cash as percentage of current liabilities (target: >30%) - Debtors days outstanding (target: <90 days) - Current ratio (maintain: >2.0:1) - Return on equity (monitor against property market returns)

8. Filing Compliance - The company's accounts and confirmation statements are currently up to date. Continue this excellent compliance record.


Prognosis

Short-term (12 months): Favourable with Monitoring

The business has a strong asset base and proven profitability. The immediate concern is cash flow management – the low cash position combined with high debtors creates vulnerability. However, if property completions proceed as expected, cash should recover substantially. The key risk is a market downturn that could delay completions or reduce property values.

Medium-term (2-3 years): Positive

The company's track record of consistent growth, low leverage, and active property management suggests continued healthy performance. The real estate market cycle will be the primary external determinant of outcomes. The business is well-positioned to weather a moderate downturn but would face challenges in a severe property market correction.

Long-term (5+ years): Cautiously Optimistic

The equity base has grown impressively, but the business remains entirely exposed to the Scottish property market. Diversification considerations (geographic or asset-class) may be worth exploring as the portfolio continues to grow.


Summary Risk Matrix

Risk Category Current Level Trend Action Required
Liquidity Risk ⚠️ Elevated Worsening Urgent cash/debtors management
Market Risk 🟡 Moderate Stable Portfolio stress testing
Concentration Risk 🟡 Moderate Stable Diversification review
Key Person Risk ⚠️ Elevated Stable Succession planning
Credit Risk ⚠️ Elevated Worsening Debtors aging analysis
Compliance Risk 🟢 Low Stable Maintain current standards

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 10 September 2026